Norgestrel

Norgestrel (CAS No.: 6533-00-2) is a synthetic steroidal progestin and progesterone analog widely utilized in biomedical research related to reproductive biology and endocrine modulation, as well as in drug discovery programs targeting hormone-regulated pathways. It exists as a racemic mixture of dextronorgestrel and levonorgestrel, with the latter representing the biologically active enantiomer responsible for high-affinity binding to progesterone receptors and subsequent modulation of gene transcription involved in ovulation inhibition, endometrial transformation, and feedback regulation of the hypothalamic–pituitary–gonadal axis. In addition to its established role in contraceptive formulations, norgestrel has been reported to exhibit neuroprotective properties, including attenuation of reactive oxygen species generation and prevention of photoreceptor cell death, supporting its investigation in models of retinal degeneration and oxidative stress–mediated injury. The compound also contains functional features enabling participation in copper-catalyzed azide–alkyne cycloaddition reactions, making it useful in chemical biology applications such as probe development and biomolecular labeling. In vitro activity is typically observed in the nanomolar to low micromolar range in assays evaluating progesterone receptor activation and downstream signaling, while in vivo studies demonstrate contraceptive efficacy in animal models, including intrauterine delivery systems. Norgestrel is commonly applied in cell-based assays examining steroid hormone signaling, as well as in animal studies exploring reproductive physiology and neuroprotection, with experimental concentrations or dosing regimens varying according to specific study design and research objectives.